Literature DB >> 15181001

Regulation of malonyl-CoA concentration and turnover in the normal heart.

Aneta E Reszko1, Takhar Kasumov, France David, Katherine R Thomas, Kathryn A Jobbins, Jie-Fei Cheng, Gary D Lopaschuk, Jason R B Dyck, Mireya Diaz, Christine Des Rosiers, William C Stanley, Henri Brunengraber.   

Abstract

The goal of this study was to test the relationship between malonyl-CoA concentration and its turnover measured in isolated rat hearts perfused with NaH(13)CO(3). This turnover is a direct measurement of the flux of acetyl-CoA carboxylation in the intact heart. It also reflects the rate of malonyl-CoA decarboxylation, i.e. the only known fate of malonyl-CoA in the heart. Conditions were selected to result in stable malonyl-CoA concentrations ranging from 1.5 to 5 nmol.g wet weight-(1). The malonyl-CoA concentration was directly correlated with the turnover of malonyl-CoA, ranging from 0.7 to 4.2 nmol.min(-) (1).g wet weight(-1) (slope = 0.98, r(2) = 0.94). The V(max) activities of acetyl-CoA carboxylase and of malonyl-CoA decarboxylase exceeded the rate of malonyl-CoA turnover by 2 orders of magnitude and did not correlate with either concentration or turnover of malonyl-CoA. However, conditions of perfusion that increased acetyl-CoA supply resulted in higher turnover and concentration, demonstrating that malonyl-CoA turnover is regulated by the supply of acetyl-CoA. The only condition where the activity of malonyl-CoA decarboxylase regulated malonyl-CoA kinetics was when the enzyme was pharmacologically inhibited, resulting in increased malonyl-CoA concentration and decreased turnover. Our data show that, in the absence of enzyme inhibitors, the rate of acetyl-CoA carboxylation is the main determinant of the malonyl-CoA concentration in the heart.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181001     DOI: 10.1074/jbc.M405488200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Molecular system bioenergetics: regulation of substrate supply in response to heart energy demands.

Authors:  Valdur Saks; Roland Favier; Rita Guzun; Uwe Schlattner; Theo Wallimann
Journal:  J Physiol       Date:  2006-09-28       Impact factor: 5.182

Review 2.  Metabolism in cardiomyopathy: every substrate matters.

Authors:  Julia Ritterhoff; Rong Tian
Journal:  Cardiovasc Res       Date:  2017-03-15       Impact factor: 10.787

3.  Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy.

Authors:  Stephen C Kolwicz; David P Olson; Luke C Marney; Lorena Garcia-Menendez; Robert E Synovec; Rong Tian
Journal:  Circ Res       Date:  2012-06-22       Impact factor: 17.367

Review 4.  Cardiac anaplerosis in health and disease: food for thought.

Authors:  Christine Des Rosiers; François Labarthe; Steven G Lloyd; John C Chatham
Journal:  Cardiovasc Res       Date:  2011-03-11       Impact factor: 10.787

5.  Fat accumulation in Caenorhabditis elegans triggered by the electrophilic lipid peroxidation product 4-hydroxynonenal (4-HNE).

Authors:  Sharda P Singh; Maciej Niemczyk; Ludwika Zimniak; Piotr Zimniak
Journal:  Aging (Albany NY)       Date:  2008-12-18       Impact factor: 5.682

6.  Mass isotopomer study of anaplerosis from propionate in the perfused rat heart.

Authors:  Takhar Kasumov; Andrea V Cendrowski; France David; Kathryn A Jobbins; Vernon E Anderson; Henri Brunengraber
Journal:  Arch Biochem Biophys       Date:  2007-03-12       Impact factor: 4.013

Review 7.  Dioxygen and Metabolism; Dangerous Liaisons in Cardiac Function and Disease.

Authors:  Aude Angelini; Xinchun Pi; Liang Xie
Journal:  Front Physiol       Date:  2017-12-12       Impact factor: 4.566

Review 8.  Loss of Metabolic Flexibility in the Failing Heart.

Authors:  Qutuba G Karwi; Golam M Uddin; Kim L Ho; Gary D Lopaschuk
Journal:  Front Cardiovasc Med       Date:  2018-06-06

9.  PHDs/CPT1B/VDAC1 axis regulates long-chain fatty acid oxidation in cardiomyocytes.

Authors:  Aude Angelini; Pradip K Saha; Antrix Jain; Sung Yun Jung; Randall L Mynatt; Xinchun Pi; Liang Xie
Journal:  Cell Rep       Date:  2021-10-05       Impact factor: 9.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.